{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.30","value":"5.29"},{"groupId":"OG001","spread":"0.28","value":"4.83"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"65"}],"units":"Participants"}],"description":"The Fagerstrom tolerance scale consists of 8 questions, each of which is scored on a 0 to 1 or 0 to 2 scale. The total score ranges from 0 to 11, with higher scores representing greater dependence.","dispersionType":"Standard Error","groups":[{"description":"Participants receive memantine hydrochloride PO BID) on days 1-81 in the absence of unacceptable toxicity.\n\nmemantine hydrochloride: Estimate participation, accrual, adherence, and retention of cancer survivors who smoke and are randomized to receive memantine (10 mg twice daily) or a matching placebo for 12 weeks.","id":"OG000","title":"Arm I - Memantine"},{"description":"Participants receive a placebo PO BID on days 1-81 in the absence of unacceptable toxicity.\n\nplacebo: Placebo by mouth through completion of 12 weeks.","id":"OG001","title":"Arm II - Placebo"}],"paramType":"LEAST_SQUARES_MEAN","populationDescription":"Participants who reported any data","reportingStatus":"POSTED","timeFrame":"12 weeks","title":"Nicotine Dependence","type":"SECONDARY","unitOfMeasure":"units on a scale"}